Suppr超能文献

过表达双趋化因子基因的人脂肪间充质干细胞在缺血性后肢模型中显示出增强的血管生成能力。

Human adipose mesenchymal stem cells overexpressing dual chemotactic gene showed enhanced angiogenic capacity in ischaemic hindlimb model.

机构信息

Department of Family Medicine, College of Medicine, Dong-A University, Busan, Korea.

Department of Medicine, College of Medicine, Catholic Kwandong University, Gangneung, Korea.

出版信息

Cardiovasc Res. 2018 Aug 1;114(10):1400-1409. doi: 10.1093/cvr/cvy086.

Abstract

AIMS

In present study, we sought to characterize the angio-vasculogenic property of human adipose mesenchymal stem cells (ASCs) overexpressing dual chemokine GCP-2 and SDF-1α (ASC-G/S) and to determine the therapeutic potential of ASC-G/S in the context of experimental ischaemia.

METHODS AND RESULTS

We generated ASC-G/S line and performed flow cytometry, quantitative (q)-PCR, Matrigel tube formation, Matrigel plug assays, and in vivo therapeutic assays using hind limb ischaemia mouse model. Q-PCR results showed that the representative pro-angiogenic factors were highly upregulated in ASC-G/S compared with ASCs single chemokine overexpressing GCP-2 (ASC-G). In addition, ASC-G/S exhibited high expression of endothelium-specific genes shch as vWF and Flk-1 and showed robust in vitro micro-vascular formation. ASC-G/S was transplanted into ischaemic mouse hind limbs and compared with control groups. ASC-G/S injection prevented limb loss and augmented blood perfusion, suggesting that ASC-G/S enhances neovascularization in hind limb ischaemia. In addition, transplanted ASC-G/S revealed high vasculogenic potential in vivo compared with transplanted ASC-G.

CONCLUSION

Our data suggest that ASC-G/S has high therapeutic effects on hind limb ischaemia via robust angiogenic and vasculogenic action.

摘要

目的

在本研究中,我们试图描述过表达双趋化因子 GCP-2 和 SDF-1α 的人脂肪间充质干细胞(ASCs)的血管生成特性,并确定 ASC-G/S 在实验性缺血情况下的治疗潜力。

方法和结果

我们生成了 ASC-G/S 系,并通过流式细胞术、定量(q)-PCR、Matrigel 管形成、Matrigel plugs 分析以及使用后肢缺血小鼠模型进行体内治疗实验来进行研究。q-PCR 结果表明,与过表达单趋化因子 GCP-2 的 ASC(ASC-G)相比,ASC-G/S 中代表性的促血管生成因子高度上调。此外,ASC-G/S 表现出高表达内皮特异性基因,如 vWF 和 Flk-1,并显示出强大的体外微血管形成能力。将 ASC-G/S 移植到缺血性小鼠后肢,并与对照组进行比较。ASC-G/S 注射可预防肢体丧失并增强血液灌注,表明 ASC-G/S 增强了后肢缺血中的新生血管形成。此外,与移植的 ASC-G 相比,移植的 ASC-G/S 显示出更高的体内血管生成潜力。

结论

我们的数据表明,通过强大的血管生成和血管生成作用,ASC-G/S 对后肢缺血具有很高的治疗效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验